0 items USD 0.00Search
Your search for "gbi research global diabetes obesity drugs market 2022 insulins gpcrs retain commercial" gave back 48430 results.
Diabetic nephropathy is a disease of the kidney glomerulus and one of the most significant complications in terms of mortality and morbidity for...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Diabetic nephropathy is a disease of the kidney glomerulus and one of the most significant complications in terms of mortality and morbidity for...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Diabetic nephropathy is a disease of the kidney glomerulus and one of the most significant complications in terms of mortality and morbidity for...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Diabetic nephropathy is a disease of the kidney glomerulus and one of the most significant complications in terms of mortality and morbidity for...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Global antidiabetics pharmaceutical market is expected to grow in near future as aging and growing population, rising income levels, and emerging...
Catalog:
NAVADHI
June 2019
Price: USD 2,000.00
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global GLP-1 Weight Loss Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period...
Catalog:
GIR
November 2023
Price: USD 4,480.00
The global GLP-1 Weight Loss Drug market size was valued at US$ million in 2022. With growing demand in downstream market, the GLP-1 Weight Loss Drug...
Catalog:
LPI
November 2023
Price: USD 3,660.00
Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
